Personalized Cancer Vaccines
Personalized cancer vaccines, a type of immunotherapy, use DNA sequencing and AI to create patient-specific treatments. Ongoing trials, like the phase 2 mRNA-based melanoma vaccine, show promise. Manufacturing involves tumor DNA analysis and AI to identify changes. Access is mainly through clinical trials, such as England’s Cancer Vaccine Launch Pad. Patient experiences, like Elliot Pfebve’s, indicate potential success. These vaccines offer a revolutionary, hopeful future for cancer treatment.
